Skip to content
  • NVDA
  • AAPL
  • MSFT
  • AMD
  • TSLA

Walmart settles U.S. government's opioid lawsuit

The settlement resolves a 2020 Justice Department complaint accusing Walmart of violating the Controlled Substances Act since 2013.

By TMRO Staff·1 min read

Key points

  • Walmart settles U.S. opioid lawsuit
  • 2020 DOJ complaint alleged violations since 2013
  • Settlement announced on 2026-08-28
  • Walmart is based in Arkansas

What happened

Walmart has reached a settlement with the U.S. government over a lawsuit concerning opioid distribution, as reported by CNBC on August 28, 2026. The settlement resolves a 2020 complaint filed by the Justice Department, which accused the Arkansas-based company of repeatedly violating the federal Controlled Substances Act since 2013.

The specific terms of the settlement were not disclosed in the report.

Why it matters

The resolution of this lawsuit removes a major legal overhang for Walmart, which had faced allegations of improper opioid dispensing practices. The case is part of broader federal efforts to hold companies accountable for their role in the opioid epidemic. The settlement may influence how other retailers and distributors approach compliance with drug laws.

Why it matters

This settlement closes a significant legal challenge for Walmart related to its role in the opioid crisis, potentially setting a precedent for other retailers facing similar federal lawsuits.

Sources

TMRO Report writes original coverage based on the material listed above.